Literature DB >> 15922720

Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice.

Ramireddy Bommireddy1, Sandra J Engle, Ilona Ormsby, Gregory P Boivin, George F Babcock, Thomas Doetschman.   

Abstract

Transforming growth factor beta1 (TGFbeta1) is a potent negative immunoregulatory molecule. We have previously shown that the autoimmune-mediated weaning-age lethality of Tgfb1-/- mice is reversed upon genetic combination with Scid or Rag null alleles. Here, we show that elimination of T but not B cells is sufficient for the reversal, but elimination of either CD4+ or CD8+ cells is not. Although elimination of B cells does not rescue TGFbeta1-deficient animals from autoimmunity, B cells are hyperresponsive to LPS in the absence of TGFbeta1. TGFbeta1 deficiency leads to activation of CD8+ T cells as suggested by down-modulation of CD8 even in the absence of CD4+ T cells. This study provides evidence that both CD4+ and CD8+ T cells, but not B cells, have the ability to cause inflammation in the absence of TGFbeta1. However, though TGFbeta1-deficient B cells are hyperresponsive to stimulation, alone they are not sufficient to cause inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922720      PMCID: PMC2804065          DOI: 10.1016/j.cellimm.2005.02.004

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  34 in total

Review 1.  Influence of genetic background on knockout mouse phenotypes.

Authors:  L P Sanford; S Kallapur; I Ormsby; T Doetschman
Journal:  Methods Mol Biol       Date:  2001

2.  Reciprocal regulation of polarized cytokine production by effector B and T cells.

Authors:  D P Harris; L Haynes; P C Sayles; D K Duso; S M Eaton; N M Lepak; L L Johnson; S L Swain; F E Lund
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

Review 3.  TGF-beta signaling: positive and negative effects on tumorigenesis.

Authors:  Lalage M Wakefield; Anita B Roberts
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

4.  TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

Authors:  Jo El J Schultz; Sandra A Witt; Betty J Glascock; Michelle L Nieman; Peter J Reiser; Stacey L Nix; Thomas R Kimball; Thomas Doetschman
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.

Authors:  Sandra J Engle; Ilona Ormsby; Sharon Pawlowski; Gregory P Boivin; Joanne Croft; Edward Balish; Tom Doetschman
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Transforming growth factor beta1 enhances platelet aggregation through a non-transcriptional effect on the fibrinogen receptor.

Authors:  J B Hoying; M Yin; R Diebold; I Ormsby; A Becker; T Doetschman
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

7.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

8.  Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.

Authors:  Yu-An Yang; Oksana Dukhanina; Binwu Tang; Mizuko Mamura; John J Letterio; Jennifer MacGregor; Sejal C Patel; Shahram Khozin; Zi-Yao Liu; Jeffrey Green; Miriam R Anver; Glenn Merlino; Lalage M Wakefield
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

9.  Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Authors:  T Takahashi; T Tagami; S Yamazaki; T Uede; J Shimizu; N Sakaguchi; T W Mak; S Sakaguchi
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

Review 10.  Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models.

Authors:  L M Wakefield; Y A Yang; O Dukhanina
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

View more
  9 in total

1.  Increase of CD4(+)CD25(+) T cells in Smad3(-/-) mice.

Authors:  Zi-Bing Wang; Yu-Fang Cui; Yu-Qing Liu; Wei Jin; Han Xu; Zhu-Jun Jiang; Ya-Xin Lu; Ying Zhang; Xiao-Lan Liu; Bo Dong
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

2.  Self-antigen recognition by TGF beta1-deficient T cells causes their activation and systemic inflammation.

Authors:  Ramireddy Bommireddy; Leena J Pathak; Jennifer Martin; Ilona Ormsby; Sandra J Engle; Gregory P Boivin; George F Babcock; Anna U Eriksson; Ram R Singh; Thomas Doetschman
Journal:  Lab Invest       Date:  2006-07-24       Impact factor: 5.662

Review 3.  Cellular and molecular basis for the regulation of inflammation by TGF-beta.

Authors:  Akihiko Yoshimura; Yu Wakabayashi; Tomoaki Mori
Journal:  J Biochem       Date:  2010-04-20       Impact factor: 3.387

Review 4.  TGFbeta1 and Treg cells: alliance for tolerance.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2007-10-30       Impact factor: 11.951

5.  Calcineurin deficiency decreases inflammatory lesions in transforming growth factor beta1-deficient mice.

Authors:  R Bommireddy; O F Bueno; J Martin; I Ormsby; H Chen; C Gard; J D Molkentin; G P Boivin; G F Babcock; T Doetschman
Journal:  Clin Exp Immunol       Date:  2009-08-18       Impact factor: 4.330

Review 6.  Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation.

Authors:  Ian B Robertson; Daniel B Rifkin
Journal:  Cytokine Growth Factor Rev       Date:  2013-07-12       Impact factor: 7.638

7.  TGF-β signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Nat Immunol       Date:  2012-05-27       Impact factor: 25.606

8.  Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance.

Authors:  Takatoshi Chinen; Kyoko Komai; Go Muto; Rimpei Morita; Naoko Inoue; Hideyuki Yoshida; Takashi Sekiya; Ryoko Yoshida; Kazuhiko Nakamura; Ryoichi Takayanagi; Akihiko Yoshimura
Journal:  Nat Commun       Date:  2011-02-08       Impact factor: 14.919

Review 9.  LncRNA-Dependent Mechanisms of Transforming Growth Factor-β: From Tissue Fibrosis to Cancer Progression.

Authors:  Philip Chiu-Tsun Tang; Ying-Ying Zhang; Jane Siu-Fan Li; Max Kam-Kwan Chan; Jiaoyi Chen; Ying Tang; Yiming Zhou; Dongmei Zhang; Kam-Tong Leung; Ka-Fai To; Sydney Chi-Wai Tang; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Noncoding RNA       Date:  2022-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.